Phasefocus Introduces Board Changes

Phasefocus Ltd, a company specialising in virtual lens technology for the microscopy and imaging sector has announced changes to its board of directors.

Paul Atherton appointed Chairman of the Board, co-founded Queensgate Instruments and was Managing Director from 1988 until its sale for more than £200 million in March 2000. Paul is also Chairman of Infinitesima, NanoVentures and Nexeon, and was Chairman of C2V and Midaz Lasers until their respective acquisitions by Thermo-Fisher in 2009 and Coherent in 2012. A board member of Imperial Innovations Group plc he has a PhD in Physics from Imperial College and an MBA from the London Business School. Paul also has extensive expertise in photonics, electronics, mechanics and nanotechnology.

Paul said, "I am delighted to be taking on this role. Phasefocus has already made some excellent progress and I am very much looking forward to working with the team to build on these achievements."

Charles Holroyd, appointed as non-executive director has been Group Business Development Director of Oxford Instruments for the past three years with responsibilities including acquisitions, divestments and joint ventures. He was formerly Managing Director of Oxford Instruments Analytical business unit and was responsible for its commercial activities and brand development in Brazil, Russia, India and China.

Martin Humphry has been appointed director and Chief Technology Officer. An inventor on a number of Phasefocus' patent applications, Martin has assumed successively higher levels of responsibility since he joined the Company in 2009, including oversight of all of its product development and R&D activities.

After five years of service with the Company, Neil Loxley resigns as  non-executive director  to take up the role as CEO of Ibex Innovations, a developer of advanced X-ray detectors, while David Baynes, CEO of Fusion IP plc and Phasefocus' outgoing Chairman, will remain a non-executive director.